Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Eps Summary of Telesis Bio, Inc.

  • Telesis Bio, Inc.'s latest annual eps in 2023 was -1.64 USD , up 3.03% from previous year.
  • Telesis Bio, Inc.'s latest quarterly eps in 2024 Q1 was -0.29 USD , up 50.85% from previous quarter.
  • Telesis Bio, Inc. reported an annual eps of -1.65 USD in 2022, down -24.06% from previous year.
  • Telesis Bio, Inc. reported an annual eps of -1.33 USD in 2021, down -114.52% from previous year.
  • Telesis Bio, Inc. reported a quarterly eps of -0.42 USD for 2024 Q2, down -2527.59% from previous quarter.
  • Telesis Bio, Inc. reported a quarterly eps of -0.35 USD for 2023 Q3, down -25.0% from previous quarter.

Annual Eps Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Eps of Telesis Bio, Inc. (2023 - 2016)

Year Eps Eps Growth
2023 -1.64 USD 3.03%
2022 -1.65 USD -24.06%
2021 -1.33 USD -114.52%
2020 -0.62 USD -210.0%
2019 -0.20 USD 90.74%
2018 -2.16 USD 3.14%
2017 -2.23 USD -150.56%
2016 -0.89 USD 0.0%

Peer Eps Comparison of Telesis Bio, Inc.

Name Eps Eps Difference
Acutus Medical, Inc. -2.81 USD 41.637%
Biotricity, Inc. -1.66 USD 1.205%
Cell MedX Corp. -0.00 USD -327900.0%
Dynatronics Corporation -1.00 USD -64.0%
Nemaura Medical Inc. -0.57 USD -187.719%
PetVivo Holdings, Inc. -0.78 USD -110.256%
RetinalGenix Technologies Inc. -0.12 USD -1266.667%
Sonendo, Inc. -0.65 USD -152.308%
Talis Biomedical Corporation -34.12 USD 95.193%
Viveve Medical, Inc. -2.65 USD 38.113%